Congenital pulmonary sequestration is a rare birth condition where a piece of lung tissue has its own blood supply and does not connect to the normal airways. People with congenital pulmonary sequestration may have cough, repeat chest infections, or trouble breathing, but some have no signs until later in childhood or adulthood. It is lifelong, and features can vary with size and location in the lung. Babies, children, and young adults are the groups most often diagnosed, and early symptoms of congenital pulmonary sequestration can include poor feeding, fast breathing, or recurrent pneumonia. Treatment often involves surgery to remove the sequestered segment, and outcomes are generally good with low mortality when managed by experienced teams.
Overview
Congenital pulmonary sequestrationSymptoms
Early signs of congenital pulmonary sequestration include repeated chest infections, persistent cough or wheeze, and shortness of breath; many have no noticeable problems. Newborns may show breathing trouble, and some cases are found on prenatal ultrasound or incidentally.
Outlook and prognosis
Most people with congenital pulmonary sequestration do well, especially after surgery to remove the extra lung segment. Babies treated early often have normal breathing and growth. When surgery isn’t needed, regular check-ins help prevent infections and track lung health over time.
Causes and risk factors
Congenital pulmonary sequestration arises before birth from abnormal lung tissue and misrouted blood vessels. It’s usually sporadic, not inherited, with no known lifestyle or environmental triggers. Risk is higher when other congenital anomalies, like diaphragmatic hernia, are present.
Genetic influences
Genetics play a limited role in congenital pulmonary sequestration; most cases appear sporadic without a clear inherited pattern. Rare familial clusters exist, so a mild underlying genetic susceptibility is possible. Routine genetic testing isn’t typically indicated unless other anomalies are present.
Diagnosis
Doctors often spot congenital pulmonary sequestration on prenatal ultrasound or postnatal chest imaging showing a lung mass. The diagnosis of congenital pulmonary sequestration is confirmed by CT angiography, MRI, or Doppler ultrasound that identifies an abnormal systemic feeding artery.
Treatment and drugs
Treatment for congenital pulmonary sequestration focuses on preventing infections and protecting healthy lung tissue. Many infants and children do well with surgery to remove the sequestered segment; timing depends on symptoms, size, and blood supply. Some centers use minimally invasive thoracoscopic surgery or, in select cases, catheter-based embolization.
Symptoms
Breathing or infection problems can show up in infancy or later childhood and sometimes in adults, often during colds or after exertion. This pattern can be caused by congenital pulmonary sequestration, a birth difference in lung tissue that doesn’t connect normally to the airways. Parents may notice early features of congenital pulmonary sequestration such as fast breathing in a newborn or repeated chest infections in a child. If these changes affect daily life, consider speaking with a healthcare professional.
Newborns or infants may breathe faster than usual or seem to work hard to get air. You may see flaring nostrils or chest muscles pulling in between the ribs, especially during a cold.
Repeated bouts of pneumonia or bronchitis can happen over months or years. Fevers, cough, and needing several courses of antibiotics are common when congenital pulmonary sequestration becomes infected. This can mean missed school or activities during recovery.
A cough that lingers for weeks or keeps coming back is common, often wet or with mucus. It may flare after colds or exercise.
Some people develop a whistling sound when breathing out or a raspy, noisy breath. This can be more noticeable when lying down or with a respiratory infection.
How people usually first notice Congenital pulmonary sequestration?
Many families first learn something is different during a routine prenatal ultrasound, when the technician sees an abnormal lung mass or a bright spot in the chest that suggests pulmonary sequestration. If it isn’t caught before birth, the first signs of congenital pulmonary sequestration are often noticed in infancy as fast or labored breathing, poor feeding, recurrent chest infections, or a doctor hearing an unusual sound in the lungs. Sometimes it’s found later in childhood when repeated pneumonias or a persistent cough prompt a chest X-ray or CT scan that reveals extra lung tissue with its own blood supply.
Types of Congenital pulmonary sequestration
Congenital pulmonary sequestration has a few well-recognized variants that differ by where the sequestered lung tissue sits and whether it connects to the airways. These variants can lead to different ages of diagnosis, kinds of infections, and how often breathing problems show up. Symptoms don’t always look the same for everyone. Knowing the main types of congenital pulmonary sequestration can help you and your care team discuss testing and treatment options, especially if you’re comparing types of congenital pulmonary sequestration before surgery.
Intralobar sequestration
Extra lung tissue sits within a normal lobe and shares its outer lining. It usually shows up later in childhood or adulthood with repeated chest infections or pneumonia. Some may notice cough, phlegm, or chest discomfort between infections.
Extralobar sequestration
Extra lung tissue sits outside the normal lung and has its own separate outer lining. It is often found in newborns or during prenatal scans and may come with other differences in the chest or abdomen. Breathing trouble can appear early, but some babies have few symptoms at first.
Systemic arterial supply
In both variants, the sequestered tissue gets blood from an artery that usually comes off the aorta. This blood flow pattern helps doctors confirm the diagnosis and plan surgery. When the artery is large, symptoms like recurrent infection or poor lung expansion may be more noticeable.
Communication with airways
Intralobar types may develop small connections to the airways over time, trapping mucus and leading to infections. Extralobar types are less likely to connect to the airways, so infections may be less frequent. This difference often shapes whether people have chronic cough or recurrent pneumonia.
What genetics can tell you about symptoms
Some people with certain chromosome changes that alter lung development genes (like FGF or VEGF pathways) have larger, isolated lung tissue that doesn’t connect to airways, leading to cough, recurrent pneumonias, or breathing trouble. Variants affecting blood vessel growth can cause abnormal systemic arteries, raising bleeding or heart strain risks.
Causes and risk factors
Congenital pulmonary sequestration happens when a small area of lung develops abnormally early in pregnancy and connects to the wrong blood vessels. Researchers are still learning how these pieces fit together. Most cases are sporadic, and no specific gene or family pattern has been confirmed. It can occur along with other birth differences, such as diaphragm or heart defects, and the extralobar type is seen more often in males. There are no proven lifestyle or environmental risk factors for congenital pulmonary sequestration during pregnancy.
Environmental and biological risk factors
Congenital pulmonary sequestration is present from birth, and many families ask what increases the chance it occurs. Most cases are sporadic with no clear trigger identified, but understanding risk factors for congenital pulmonary sequestration can help frame expectations. Researchers are still exploring how outside influences interact with our inner biology. Below are environmental and biological elements clinicians consider during pregnancy and after delivery.
The condition is thought to arise when lung tissue develops abnormally in the first trimester. Disruptions during this window can increase the likelihood of a sequestered segment forming.
Variations in how fetal blood vessels form can feed isolated lung tissue from a body artery rather than the lung’s usual circulation. This vascular pattern increases the chance that sequestration is present.
Conditions like congenital diaphragmatic hernia or digestive tract malformations sometimes occur alongside sequestration, reflecting shared early development pathways. When these are seen on prenatal imaging, the chance of also finding sequestration is higher.
Extralobar sequestration has been reported somewhat more often in male fetuses. This pattern suggests a small sex-related biological influence on risk.
Genetic risk factors
Congenital pulmonary sequestration is usually a one-off developmental change, not something that runs in families. Most cases have no identifiable inherited cause, and the chance of it appearing again in a family appears low. Rarely, it occurs alongside other birth differences, such as congenital diaphragmatic hernia, where a shared genetic basis may be present. People with the same risk factor can have very different experiences.
Mostly sporadic: Most congenital pulmonary sequestration cases arise without an inherited cause. They reflect a developmental change in early lung formation rather than a family trait.
Family history rare: Having a relative with this condition seldom increases personal risk. Documented familial clusters are exceptional, and no consistent inheritance pattern has been confirmed.
Syndromic associations: Some cases appear alongside other birth differences, such as congenital diaphragmatic hernia. In those combined presentations, a shared genetic cause may underlie the overall pattern rather than the sequestration alone.
Somatic lesion changes: Some congenital lung malformations show non-inherited, tissue-only changes in growth pathways. Hybrid lesions that combine sequestration with nearby airway malformation may carry these changes only in the affected tissue, not throughout the body.
Chromosomal changes uncommon: Large chromosomal differences are uncommon in isolated congenital pulmonary sequestration. When they are found, they usually relate to additional anomalies seen on imaging rather than the sequestration itself.
No single-gene cause: No single gene has been proven to cause this condition in a predictable way. Rare family reports suggest a possible susceptibility in some lineages, but evidence remains limited.
Symptoms not predictive: Genetics do not predict early symptoms of congenital pulmonary sequestration. Symptom timing and severity usually reflect the size, blood supply, and location of the sequestered segment rather than inherited risk.
Testing considerations: For isolated congenital pulmonary sequestration, routine genetic testing is generally not recommended. Testing may be considered when it occurs with other structural differences or a relevant family history.
Lifestyle risk factors
Congenital pulmonary sequestration is present from birth and not caused by lifestyle, but daily habits can influence breathing comfort, infection frequency, and recovery after treatment. In particular, lifestyle risk factors for congenital pulmonary sequestration relate to how easily the lungs clear mucus and how likely infections or bleeding are to occur. Thoughtful choices can reduce flare‑ups and improve exercise tolerance. Discuss changes with your clinician, especially if surgery is planned or you have recurrent infections.
Tobacco or nicotine vapor irritates airways and increases infection and bleeding risk in the abnormal lung segment. Quitting lowers airway inflammation and reduces pneumonia and hemoptysis episodes.
Regular moderate aerobic movement can improve ventilation, help mucus clearance, and build stamina for daily tasks. Avoid all‑out exertion during active chest infections or significant shortness of breath.
Staying well hydrated and practicing prescribed airway clearance (like huff cough or chest physiotherapy) may limit mucus stasis in connected airways and adjacent lung. This can reduce the frequency and severity of infections linked to the sequestered area.
A balanced diet that prevents undernutrition supports immune defenses against lung infections. Avoiding obesity can improve diaphragm mechanics and breathing effort, and lowers postoperative complications if surgery is needed.
Risk prevention
Because this condition develops before birth, you can’t prevent the extra lung tissue from forming. Prevention is about lowering risk, not eliminating it completely. For people with congenital pulmonary sequestration, the focus is on avoiding infections, easing breathing issues, and planning care at the right time. Parents may first notice early symptoms of congenital pulmonary sequestration such as repeated chest infections or a persistent cough, so early follow-up can make a difference.
If found during pregnancy, regular scans can track the size and blood flow of the sequestration. This helps plan delivery at a hospital ready for newborn breathing support if needed.
Staying up to date on recommended shots, including flu and pneumococcal vaccines, lowers the chance of chest infections. This is especially helpful for children living with congenital pulmonary sequestration.
Avoid tobacco smoke, vaping aerosols, and indoor pollutants to protect sensitive lungs. Cleaner air can reduce coughing and infections in people with congenital pulmonary sequestration.
Seek care early for fever, worsening cough, fast breathing, or chest pain. Quick treatment of lung infections can prevent complications in congenital pulmonary sequestration.
Transmission
Congenital pulmonary sequestration isn’t contagious and can’t be transferred through contact, coughs, or close living. It forms before birth when a small area of lung develops separately with its own blood supply; in most cases there’s no known cause, and it doesn’t follow a typical inherited pattern.
Because genetic transmission of congenital pulmonary sequestration is uncommon, the chance of it recurring in a family is usually low; if it appears alongside other birth differences or a known syndrome, a genetics team can explain how congenital pulmonary sequestration is inherited in that setting. There’s no need for isolation or special infection precautions for people living with this condition.
When to test your genes
Consider genetic testing if there’s a family history of congenital lung malformations, a prenatal ultrasound suggests an abnormal lung mass, or a newborn/child has recurrent pneumonia in the same lung area. Testing can clarify diagnosis, guide surgical planning, and inform monitoring. Discuss results with a genetics-informed clinician to tailor care.
Diagnosis
Congenital pulmonary sequestration is often found before birth or when a baby or child has breathing trouble or repeated chest infections. You might notice small changes in daily routines, like an infant breathing fast during feeds or a preschooler with coughs that keep coming back. Doctors usually begin with imaging to look for a pocket of lung tissue that doesn’t connect to the airways and has an unusual blood vessel feeding it. The diagnosis of congenital pulmonary sequestration often combines prenatal imaging with postnatal scans that map the blood supply to confirm what’s seen.
Sonographers look for a well-defined lung mass and may see a feeding artery arising from the aorta. The size, location, and any fluid around the lungs help guide monitoring during pregnancy.
MRI provides clearer detail of the lung mass and nearby structures without radiation. It helps differentiate sequestration from other congenital lung lesions.
Clinicians check for rapid breathing, low oxygen, or chest asymmetry after birth. Physical findings plus early imaging help decide if urgent treatment is needed.
A simple X-ray can show a mass or area that looks unusually dense in the lung. It helps flag a suspected lesion and guides the next imaging step.
Stages of Congenital pulmonary sequestration
Congenital pulmonary sequestration does not have defined progression stages. It’s a structural difference in lung tissue present from birth, so it doesn’t typically “advance” over time; instead, symptoms may be absent, show up during infections, or be found by chance on imaging. Early symptoms of congenital pulmonary sequestration can include recurrent chest infections, lingering cough, or breathing trouble in infancy or childhood, though some cases are first noted on prenatal ultrasound. Different tests may be suggested to help confirm what’s going on, such as prenatal ultrasound or MRI and, after birth, a contrast CT scan or echocardiography to map the abnormal blood vessel, with follow-up guided by symptoms and specialist advice.
Outlook and prognosis
Breathing problems from congenital pulmonary sequestration can range from none at all to recurrent chest infections or trouble keeping up during play or exercise. The outlook is not the same for everyone, but many babies and children who have a small, quiet sequestration and no symptoms are simply watched with regular check-ins and imaging. When symptoms do show up—like repeated pneumonia in the same area, persistent cough, or poor weight gain—surgery is often recommended and is commonly curative.
Understanding the prognosis can guide planning and day-to-day choices, including what to do if early symptoms of congenital pulmonary sequestration appear during a cold or after activity. Most children and adults do well after treatment, especially with minimally invasive surgery that removes the abnormal lung tissue and ties off the extra blood vessel feeding it. Serious complications such as significant bleeding, lung infection that spreads, or breathing failure are uncommon in modern care; when surgery is needed, operative risk is usually low in experienced centers, and long-term survival is excellent.
Over time, most people regain normal or near‑normal lung function after successful surgery, and many return to sports and active work without limits. If the sequestration is left in place, the main risks are repeat infections, inflammation, or, rarely, bleeding or air leaks; malignant change is very rare. Mortality directly from congenital pulmonary sequestration is rare today, particularly when identified early and managed by a pediatric or thoracic team. Talk with your doctor about what your personal outlook might look like, including how often to follow up, when to consider surgery, and what signs should prompt a call between visits.
Long-term effects
Congenital pulmonary sequestration can have very different long-term courses. Some people stay well for years, while others deal with repeat chest infections or limits with activity. Long-term effects vary widely, and the outlook often depends on the size and location of the sequestered tissue. Early symptoms of congenital pulmonary sequestration can be subtle in infancy, then become clearer with growth.
Repeat chest infections or pneumonia can occur over time. These flares may leave a lingering cough and tiredness.
Some have shortness of breath with exercise or play. Lung capacity may be slightly below average but can remain stable for years.
A persistent cough, sometimes with phlegm, may continue between infections. Wheezing can come and go, especially with colds.
Rarely, people cough up small amounts of blood. This tends to happen during or after infections and should be evaluated promptly.
How is it to live with Congenital pulmonary sequestration?
Living with congenital pulmonary sequestration can range from barely noticing anything to dealing with cough, chest infections, or shortness of breath during routine activities, especially if the sequestered lung tissue gets infected. Many feel more at ease after a clear plan is set—often monitoring in mild cases or surgery to remove the isolated tissue when symptoms or complications arise—because it reduces flare-ups and uncertainty. Day to day, this might mean pacing physical activity, recognizing early signs of infection, and keeping up with follow-up imaging. For families and partners, the main impact is supporting appointments and recovery if surgery is chosen, and sharing a calm, watchful approach when respiratory symptoms appear.
Treatment and drugs
Treatment for congenital pulmonary sequestration focuses on removing or shutting down the abnormal piece of lung that doesn’t connect to the airway and draws blood from an unusual artery. For many, the standard approach is surgery to remove the sequestered segment or lobe (segmentectomy or lobectomy), which helps prevent repeat chest infections and bleeding and usually allows the rest of the lungs to work better. In selected cases, especially before or shortly after birth or when surgery carries higher risk, doctors may use a catheter-based procedure called arterial embolization to block the feeding vessel; sometimes this is used alone, and sometimes to make later surgery safer. Care teams tailor timing: newborns with breathing problems from congenital pulmonary sequestration may need early treatment, while older children or adults with mild or no symptoms may have planned surgery when it’s safest. Your doctor can help weigh the pros and cons of each option.
Non-drug treatment
Congenital pulmonary sequestration care focuses on staying ahead of lung infections, tracking breathing, and deciding the right timing for procedures. Some babies and children have no symptoms, while others deal with cough, wheeze, or repeat chest infections that disrupt daily life. Non-drug treatments often lay the foundation for staying well before and after surgery. These approaches are individualized based on age, size of the sequestration, and whether symptoms are present.
Regular checkups and chest imaging help track the size and blood supply of the sequestered lung tissue. This approach is often used when a child has no symptoms.
Chest physiotherapy and breathing exercises help loosen and move mucus, lowering the risk of infection. This can be taught by a respiratory therapist and practiced at home.
Staying up to date on routine vaccines, including flu and pneumonia vaccines when advised, reduces lung infections. Good handwashing and quick care for colds can help prevent complications in congenital pulmonary sequestration.
Ensuring steady weight gain supports immune function and recovery if surgery is planned. A dietitian can tailor tips for infants, children, or teens.
Your genes may have an impact on how drugs work for you
Most medicines used around congenital pulmonary sequestration are supportive—like antibiotics for infections or pain control—and your genes can affect how your body processes them, changing dose needs or side‑effect risks. Rarely, genetic differences influence anesthesia response during surgery, guiding drug choice and monitoring.
Pharmacological treatments
Most people with congenital pulmonary sequestration ultimately need surgery to remove the abnormal lung tissue, since that is the only definitive fix. Medicines are used to control infections and ease breathing or heart strain before or after surgery, or if surgery is delayed. Drugs that target symptoms directly are called symptomatic treatments. Choices depend on age, symptoms, and whether there’s an active chest infection or signs of heart stress.
Doctors treat bacterial chest infections linked to congenital pulmonary sequestration with antibiotics such as amoxicillin‑clavulanate or azithromycin. More severe infections may need hospital antibiotics like ceftriaxone given by IV. The specific drug is guided by local resistance patterns and any allergy history.
If a large blood vessel feeding the sequestration causes signs of heart strain or fluid buildup, diuretics like furosemide can help the body shed extra fluid. This may ease breathing and feeding until surgery is planned. Kidney function, hydration, and electrolytes are monitored while on therapy.
For wheeze or chest tightness during infections, quick‑relief inhalers such as albuterol (salbutamol) can open the airways. They help symptoms but do not treat the underlying sequestration. A spacer or nebulizer can make delivery easier for young children.
Short courses of oral prednisolone or inhaled steroids like budesonide may reduce airway swelling around an infection or after surgery. They are used cautiously and for limited periods to avoid side effects. Your care team will tailor dose and duration to the situation.
Genetic influences
It’s natural to ask whether family history plays a role. For most people, congenital pulmonary sequestration develops as a one-time change early in fetal lung formation rather than something passed down from a parent. No single gene has been consistently linked to it, and reports of multiple affected relatives are uncommon. Because of this, genetic testing is not routinely recommended when sequestration is the only finding, though a genetics visit may be suggested if there are additional structural differences on ultrasound or exam. People sometimes ask is congenital pulmonary sequestration hereditary; current evidence suggests the chance of it happening again in a future pregnancy is low, but your care team can tailor that discussion to your family’s history. When congenital pulmonary sequestration appears with other birth differences, a genetics professional can review testing options and explain what results might mean for you and your family.
Is Congenital pulmonary sequestration genetic?
Genetics play a limited role in congenital pulmonary sequestration; most cases appear sporadic without a clear inherited pattern. Rare familial clusters exist, so a mild underlying genetic susceptibility is possible. Routine genetic testing isn’t typically indicated unless other anomalies are present.
Pharmacogenetics—how genetics influence drug effects
For people preparing for surgery to remove a sequestration, medication choices—especially anesthesia and pain control—may be influenced by genetics. This can help lower anesthesia risks in congenital pulmonary sequestration. Genetic testing can sometimes identify how your body handles certain anesthetics or pain medicines, which helps the team plan safer care. For example, a rare inherited risk called malignant hyperthermia can cause dangerous reactions to specific anesthesia gases, so doctors will choose alternative drugs if there’s a known family history or a positive test. Differences in drug-processing enzymes can also change how well codeine or tramadol relieve pain, or how likely NSAIDs are to irritate the stomach or increase bleeding risk, so your team may adjust the medicine or dose. Less commonly, variations that affect a blood enzyme used to break down certain muscle relaxants can lead to prolonged muscle weakness and delayed breathing recovery after surgery, and your anesthesiologist will avoid those medicines if this is known. Most treatment decisions still rely on clinical factors like age, liver and kidney function, and infection history; genes are just one piece of the picture, so share any past anesthesia issues in you or close relatives.
Interactions with other conditions
In people with congenital pulmonary sequestration, other conditions can shape day-to-day symptoms and the care plan. Doctors call it a “comorbidity” when two conditions occur together. Congenital pulmonary sequestration may appear alongside other birth differences in the chest, especially congenital pulmonary airway malformation (CPAM) or a congenital diaphragmatic hernia, and this pairing can change breathing patterns and influence when surgery is recommended. Some babies—particularly those with an extralobar type—also have congenital heart disease; in that setting, the abnormal blood supply to the sequestration can add to the heart’s workload and raise the risk of heart strain or high lung pressure. For older children and adults, infections such as pneumonia can develop in the affected area, and if asthma or bronchiectasis is also present, cough and breathlessness may be more intense during flares. Because early symptoms of congenital pulmonary sequestration can be overshadowed by another condition, coordinated care with lung and heart specialists helps time treatment and surgery as safely as possible.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Families and midwives once noticed babies who breathed fast, tired with feeding, or had repeated chest infections that didn’t match the usual patterns of pneumonia. Some children grew into adolescence with a stubborn cough and poor exercise tolerance, while others had no symptoms and were only found to have an unusual spot in the lung during a chest X-ray for something else. These everyday observations set the stage for what is now called congenital pulmonary sequestration.
First described in the medical literature as isolated “lung masses” in the early 1900s, these findings puzzled doctors because the tissue looked like lung but didn’t connect to the normal airways. Over time, surgeons reported that this tissue was being supplied by an artery coming straight from the body’s main vessel rather than the usual lung circulation. That unusual blood supply became a key clue. Initially understood only through symptoms, later imaging with angiography, and then CT and MRI, confirmed that some of these lesions sat within the lung and others outside it, leading to the commonly used terms intralobar and extralobar types.
From early theories to modern research, the story of congenital pulmonary sequestration reflects the broader growth of chest medicine and surgery. In the mid-20th century, as anesthesia and thoracic surgery improved, surgeons began removing these abnormal pieces of lung to prevent infections and bleeding. Reports from those operations helped define how often each type occurs and how they differ in newborns versus older children and adults. In newborns, extralobar sequestrations were sometimes found alongside other developmental differences in the chest or diaphragm, while intralobar sequestrations more often showed up later with infections.
With the rise of prenatal ultrasound in the late 20th century, doctors started detecting congenital pulmonary sequestration before birth as a solid or mixed mass in the fetus’s chest. Color Doppler, which shows blood flow, allowed clinicians to spot the feeding artery, turning what had once been a surprise finding into a condition that could be monitored during pregnancy. In some centers, minimally invasive procedures to block the feeding vessel before or after birth were explored, adding to surgical options after delivery.
In recent decades, knowledge has built on a long tradition of observation. The concept of “congenital lung malformations” emerged, grouping sequestration with related conditions and recognizing that some lesions can blend features. This helped explain why not every case fits neatly into a single box and why management needs to be tailored. Today, the history of congenital pulmonary sequestration is a progression from bedside observation to imaging-based diagnosis and planned treatment, with ongoing follow-up showing that many people do well after careful surgical or interventional care. Knowing the condition’s history helps explain why early symptoms of congenital pulmonary sequestration can be subtle and why modern imaging plays such a central role in finding and managing it.